Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1964 4
1965 4
1966 14
1967 26
1968 29
1969 39
1970 49
1971 50
1972 54
1973 75
1974 81
1975 150
1976 147
1977 178
1978 212
1979 252
1980 348
1981 397
1982 578
1983 713
1984 767
1985 907
1986 921
1987 955
1988 961
1989 1005
1990 1024
1991 997
1992 922
1993 932
1994 803
1995 797
1996 840
1997 733
1998 678
1999 588
2000 578
2001 558
2002 515
2003 502
2004 517
2005 516
2006 514
2007 472
2008 479
2009 496
2010 489
2011 467
2012 446
2013 474
2014 478
2015 420
2016 395
2017 368
2018 306
2019 342
2020 359
2021 332
2022 299
2023 289
2024 99

Text availability

Article attribute

Article type

Publication date

Search Results

26,883 results

Results by year

Filters applied: . Clear all
Page 1
Verapamil in arrhythmia.
Krikler DM. Krikler DM. Br J Clin Pharmacol. 1986;21 Suppl 2(Suppl 2):183S-189S. doi: 10.1111/j.1365-2125.1986.tb02869.x. Br J Clin Pharmacol. 1986. PMID: 3530300 Free PMC article. Review.
The antiarrhythmic effects of verapamil were observed before it was appreciated that it was a calcium ion-antagonist. Intravenous verapamil is highly effective in the termination of paroxysmal reciprocating atrioventricular tachycardia, whether associated with preex …
The antiarrhythmic effects of verapamil were observed before it was appreciated that it was a calcium ion-antagonist. Intravenous …
Verapamil and the myocardium.
Nayler WG, Krikler D. Nayler WG, et al. Postgrad Med J. 1974 Jul;50(585):441-6. doi: 10.1136/pgmj.50.585.441. Postgrad Med J. 1974. PMID: 4619835 Free PMC article. Review.
Verapamil differs from propranolol, however, in that it does not antagonize the cardiac beta-adrenoceptors and it dilates the coronary vessels. Verapamil probably owes its activity to its ability to interfere with the inwards displacement of calcium ions across card …
Verapamil differs from propranolol, however, in that it does not antagonize the cardiac beta-adrenoceptors and it dilates the coronar …
Verapamil for cluster headache. Clinical pharmacology and possible mode of action.
Tfelt-Hansen P, Tfelt-Hansen J. Tfelt-Hansen P, et al. Headache. 2009 Jan;49(1):117-25. doi: 10.1111/j.1526-4610.2008.01298.x. Headache. 2009. PMID: 19125880 Review.
Verapamil is used mainly in cardiovascular diseases. High-dose verapamil (360-720 mg) is, however, currently the mainstay in the prophylactic treatment of cluster headache. ...The access of verapamil to the central nervous system is therefore limited. The cli …
Verapamil is used mainly in cardiovascular diseases. High-dose verapamil (360-720 mg) is, however, currently the mainstay in t …
Verapamil-rifampin interaction.
Barbarash RA. Barbarash RA. Drug Intell Clin Pharm. 1985 Jul-Aug;19(7-8):559-60. doi: 10.1177/106002808501900712. Drug Intell Clin Pharm. 1985. PMID: 4028962
A case of verapamil-rifampin interaction is presented in a patient receiving verapamil for supraventricular tachycardia (SVT) and rifampin for pulmonary tuberculosis. The patient experienced recurrent symptomatic SVT, despite receiving verapamil 480 mg po q6h …
A case of verapamil-rifampin interaction is presented in a patient receiving verapamil for supraventricular tachycardia (SVT) …
Verapamil.
Ruedy J. Ruedy J. Clin Invest Med. 1981;4(2):129-47. Clin Invest Med. 1981. PMID: 7026099 Review. No abstract available.
Clinical pharmacokinetics of verapamil.
Hamann SR, Blouin RA, McAllister RG Jr. Hamann SR, et al. Clin Pharmacokinet. 1984 Jan-Feb;9(1):26-41. doi: 10.2165/00003088-198409010-00002. Clin Pharmacokinet. 1984. PMID: 6362951 Review.
Verapamil is widely used in the treatment of supraventricular tachyarrhythmias as well as for hypertension and control of symptoms in angina pectoris. Unlike other calcium antagonists, detailed pharmacokinetic data are available for verapamil. Plasma concentrations …
Verapamil is widely used in the treatment of supraventricular tachyarrhythmias as well as for hypertension and control of symptoms in …
Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.
McTavish D, Sorkin EM. McTavish D, et al. Drugs. 1989 Jul;38(1):19-76. doi: 10.2165/00003495-198938010-00003. Drugs. 1989. PMID: 2670511 Review.
Although verapamil is a well-established treatment for angina, cardiac arrhythmias and cardiomyopathies, this review reflects current interest in calcium antagonists as anti-hypertensive agents by focusing on the role of verapamil in hypertension. ...Sustained relea …
Although verapamil is a well-established treatment for angina, cardiac arrhythmias and cardiomyopathies, this review reflects current …
Verapamil (Isoptin, Knoll; Calan, Searle).
McMahon MT, Sheaffer SL. McMahon MT, et al. Drug Intell Clin Pharm. 1982 Jun;16(6):443-7. doi: 10.1177/106002808201600601. Drug Intell Clin Pharm. 1982. PMID: 7047130 Review.
Verapamil is a calcium antagonist that is pharmacologically different from other currently marketed antiarrhythmics. ...Because of its short plasma half-life, other agents or cardioversion can be used if verapamil is unsuccessful. The use of verapamil in the …
Verapamil is a calcium antagonist that is pharmacologically different from other currently marketed antiarrhythmics. ...Because of it …
Verapamil: full spectrum calcium channel blocking agent: an overview.
Guerrero JR, Martin SS. Guerrero JR, et al. Med Res Rev. 1984 Jan-Mar;4(1):87-109. doi: 10.1002/med.2610040106. Med Res Rev. 1984. PMID: 6319840 Review.
Oral verapamil approved for use in all forms of angina, with its additional heart rate-controlling properties has undergone extensive clinical investigation and use since its initial development and has been demonstrated to be safe, well-tolerated and effective over a broa …
Oral verapamil approved for use in all forms of angina, with its additional heart rate-controlling properties has undergone extensive …
Verapamil pharmacokinetics.
Meredith PA, Elliott HL, Reid JL. Meredith PA, et al. Br J Clin Pharmacol. 1986 May;21(5):554-5. doi: 10.1111/j.1365-2125.1986.tb02846.x. Br J Clin Pharmacol. 1986. PMID: 3718816 Free PMC article. No abstract available.
26,883 results
You have reached the last available page of results. Please see the User Guide for more information.